Healthcare stocks were trading in red, with the BSE Healthcare index decreasing 964.5 points or 2.15% at 43811.25 at 13:42 IST.
Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities.
The Nikon 5x15 HG Monocular is tiny, but it promises the same high-quality build and lens of Nikon's other optical devices.
Supriya Lifescience Chairman and Whole-Time Director Satish Wagh said he was confident of achieving 22 per cent year-on-year ...
Satish Wagh, Chairman and Whole-Time Dir, Supriya Lifescience, stated that it has invested ₹250 crore across two plants, and these expansions are set to enhance the company’s sales capacity and ...
Bulk-drugs maker Supriya Lifescience Ltd, which was founded in 1987 and operates in therapeutic segments such as ...
Supriya Lifescience Ltd. is confident of exceeding its FY25 margin guidance and surpassing the targeted Rs 1,000-crore revenue in FY27, driven by its foray into regulated markets and the scale-up of ...
Mumbai, Dec 17 (PTI) Supriya Lifescience on Tuesday inaugurated a Rs 120-crore multipurpose Active Pharmaceutical Ingredients (APIs) production block in Ratnagiri district's Lote Parshuram. The unit ...
What does 2025 hold for India's IT services sector? 2025 may be the year of EVs in India, dominated by SUV launches The facility, developed with an investment of approximately Rs 120 crore, adds a ...
Mumbai: Supriya Lifescience Ltd. has acquired approval from Brazil's health authority, ANVISA (Agência Nacional de Vigilância Sanitária), for Esketamine Hydrochloride This approval will help the ...
The market rebounded after a seven-day losing streak and closed 0.3 percent higher on November 19, with breadth favouring bulls. About 1,628 shares gained, while 846 shares declined on the NSE.
The Exchange has sought clarification from Supriya Lifescience Ltd on January 1, 2025, with reference to news appeared in https://www.business-standard.com/ dated January 1, 2025 quoting "Supriya ...